Other Private Equity/Strategic Investments
Pharma-industry focused Graph AI in talks to raise $14-M led by Insight Partners
Hyderabad- and California (US)-based pharmaceutical-sector-focused AI company Graph AI is in talks to raise $14-M (approximately Rs.133-Cr) in a Series A funding round. The transaction is expected to be led by US-based Insight Partners, with participation from existing investor Bessemer Venture Partners.Founded in 2024 by Raghav Parvataraju, Vijay Ponukumati, Mohan Konyala, and Ashutosh Bordekar, the firm provides an AI-native platform called Graph Safety, designed to automate adverse drug event monitoring, regulatory submissions, and aggregate safety intelligence for the pharmaceutical and biotech industries. Graph AI intends to use the new funds to add capabilities to its platform across the safety value chain.This potential fundraising follows an earlier seed round in which the company raised $3-M led by Bessemer Venture Partners.
In Oct 2025, Graph AI had attracted about $3 M from Bessemer.For FY25, Graph AI had reported about INR 1 Cr in Operating Income.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
